AllianceBernstein’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$841K Hold
31,990
﹤0.01% 2412
2025
Q4
$841K Sell
31,990
-1,270
-4% -$23.3K ﹤0.01% 2425
2025
Q3
$465K Sell
33,260
-2,380
-7% -$27.1K ﹤0.01% 2717
2025
Q2
$341K Buy
35,640
+18,070
+103% +$172K ﹤0.01% 2852
2025
Q1
$163K Hold
17,570
﹤0.01% 2973
2024
Q4
$244K Hold
17,570
﹤0.01% 2968
2024
Q3
$413K Hold
17,570
﹤0.01% 2758
2024
Q2
$281K Buy
+17,570
New +$302K ﹤0.01% 2939

Other funds holding TYRA

AllianceBernstein's TYRA Position: Q1 2026 in Review

AllianceBernstein held its Tyra Biosciences (TYRA) position steady in Q1 2026 at 31,990 shares worth $841K. The position accounts for ﹤0.01% of the portfolio, ranked #2412.

AllianceBernstein first reported a position in TYRA in Q2 2024 and has held it in 8 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • AllianceBernstein held 31,990 shares of Tyra Biosciences worth $841K as of Q1 2026.
  • AllianceBernstein left its Tyra Biosciences share count unchanged in Q1 2026.
  • Tyra Biosciences made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2412 holding.
  • AllianceBernstein first reported a position in Tyra Biosciences in Q2 2024 and has held it in 8 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.